Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands

Intracellular Poly(I:C) Initiated Gastric Adenocarcinoma Cell Apoptosis and Subsequently Ameliorated NK Cell Functions

(2013) Jing Qu et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Immunogenic Cell Death in Cancer Therapy

(2012) Guido Kroemer et al.   Annual Review of Immunology

Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense

(2012) Shaherin Basith et al.   ARCHIVES OF PHARMACAL RESEARCH

Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

(2012) Charles C. L. Tong et al.   IMMUNOLOGIC RESEARCH

Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo

(2012) Qingqiong Luo et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion

(2012) Huan Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors

(2012) H. Shime et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting pattern recognition receptors in cancer immunotherapy

(2012) Nadège Goutagny et al.   Targeted Oncology

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

(2012) Erika Vacchelli et al.   OncoImmunology

Anticancer function of polyinosinic-polycytidylic acid

(2011) Yu-sheng Cheng et al.   CANCER BIOLOGY & THERAPY

Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

(2011) Edit Kovalcsik et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

(2011) Sally M. Amos et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Lung cancer and Toll-like receptors

(2011) Aldo Pinto et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells

(2011) Kirsten Kübler et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC

(2011) Eva Lion et al.   PLoS One

Preclinical models of HPV+ and HPV− HNSCC in mice: An immune clearance of HPV+ HNSCC

(2009) Robin Williams et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas

(2009) Camilla Rydberg et al.   IMMUNOLOGY

Toll-like receptor agonists in cancer therapy

(2009) Sylvia Adams   Immunotherapy

Immunogenic death of colon cancer cells treated with oxaliplatin

(2009) A Tesniere et al.   ONCOGENE

The Inflammatory Response to Cell Death

(2008) Kenneth L. Rock et al.   Annual Review of Pathology-Mechanisms of Disease

Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors

(2008) Shuo Peng et al.   CANCER SCIENCE